114645-19-1

Basic information

• Product Name: N-alpha-t-Butyloxycarbonyl-L-isoleucinyl-diazomethane, (3S,4S)-3-Boc-amino-1-diazo-4-methyl-2-hexanone
• Synonyms: N-alpha-t-Butyloxycarbonyl-L-isoleucinyl-diazomethane, (3S,4S)-3-Boc-amino-1-diazo-4-methyl-2-hexanone
• CAS NO: 114645-19-1
• Molecular Formula: C₁₂H₂₁N₃O₃
• Molecular Weight: 255.316
• Mol File: 114645-19-1.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-alpha-t-Butyloxycarbonyl-L-isoleucinyl-diazomethane, (3S,4S)-3-Boc-amino-1-diazo-4-methyl-2-hexanone(CAS DataBase Reference)
• NIST Chemistry Reference: N-alpha-t-Butyloxycarbonyl-L-isoleucinyl-diazomethane, (3S,4S)-3-Boc-amino-1-diazo-4-methyl-2-hexanone(114645-19-1)
• EPA Substance Registry System: N-alpha-t-Butyloxycarbonyl-L-isoleucinyl-diazomethane, (3S,4S)-3-Boc-amino-1-diazo-4-methyl-2-hexanone(114645-19-1)

Safety Data

• Hazardous Substances Data: 114645-19-1(Hazardous Substances Data)

Upstream product

• 186581-53-3 diazomethane 
• 13139-16-7 N-(tert-butyloxycarbonyl)-L-isoleucine 
• 66866-47-5 Boc-Ile-O-COOiBu 
• 24424-99-5 di-tert-butyl dicarbonate 
• 98807-42-2 Boc-Ile-O-COOEt 
• 73-32-5 L-isoleucine 

Downstream Products

• 218608-82-3 N-(t-butyloxycarbonyl)-β-homoisoleucine 
• 145057-72-3 <(2S,3S)-N-butoxycarbonylisoleucinyl>-methyl-phenyl ketone 
• 197172-44-4 (S)-2-(N'-tert-Butoxycarbonyl-N-{(R)-2-[(2S,3S)-2-((S)-sec-butyl)-1-(tert-butyl-dimethyl-silanyl)-4-oxo-azetidin-3-yloxy]-4-methyl-pentanoyl}-hydrazino)-4-methyl-pentanoic acid benzyl ester 
• 197172-45-5 (S)-2-(N'-tert-Butoxycarbonyl-N-{(S)-2-[(2S,3S)-2-((S)-sec-butyl)-1-(tert-butyl-dimethyl-silanyl)-4-oxo-azetidin-3-yloxy]-4-methyl-pentanoyl}-hydrazino)-4-methyl-pentanoic acid benzyl ester 
• 197172-42-2 (R)-2-[(2S,3S)-2-((S)-sec-Butyl)-1-(tert-butyl-dimethyl-silanyl)-4-oxo-azetidin-3-yloxy]-4-methyl-pentanoic acid benzyl ester 
• 197172-43-3 (S)-2-[(2S,3S)-2-((S)-sec-Butyl)-1-(tert-butyl-dimethyl-silanyl)-4-oxo-azetidin-3-yloxy]-4-methyl-pentanoic acid benzyl ester 
• 1375000-12-6 C₃₀H₃₇N₅O₆ 

Relevant articles and documents

Antiplasmodial activity of new 4-aminoquinoline derivatives against chloroquine resistant strain

Emergence and spread of multidrug resistant strains of Plasmodium falciparum has severely limited the antimalarial chemotherapeutic options. In order to overcome the obstacle, a set of new side-chain modified 4-aminoquinolines were synthesized and screened against chloroquine-sensitive (3D7) and chloroquine-resistant (K1) strains of P. falciparum. The key feature of the designed molecules is the use of methylpiperazine linked α, β3- and γ-amino acids to generate novel side chain modified 4-aminoquinoline analogues. Among the evaluated compounds, 20c and 30 were found more potent than CQ against K1 and displayed a four-fold and a three-fold higher activity respectively, with a good selectivity index (SI = 5846 and 11,350). All synthesized compounds had resistance index between 1.06 and >14.13 as against 47.2 for chloroquine. Biophysical studies suggested that this series of compounds act on heme polymerization target.

CuI-promoted one-pot synthesis of N-boc protected β-ketotriazole amino acids: Application in the synthesis of new class of dipeptidomimetics

One-pot click chemistry of Nα-Boc-bromomethylketones, NaN3 and propiolic acid affords N-Boc protected 1,4- disubstituted 1,2,3-β-ketotriazole acids in good to excellent yield. The use of CuI as catalyst and DMSO as solvent leads the click react

Enantiospecific synthesis of pyridinones as versatile intermediates toward asymmetric piperidines

The enantiospecific syntheses of pyridinones from amino acids via a gold-catalyzed strategy are reported. Excellent stereocontrol was observed during the cyclization. This approach provides a straightforward tool for further synthetic applications toward

Homologation of α-amino acids to β-amino acids: 9-Fluorenylmethyl chloroformate as a carboxyl group activating agent for the synthesis of Nα-protected aminoacyldiazomethanes

An efficient and stereospecific homologation of urethane-protected α-amino acids to β-amino acids by Arndt-Eistert approach using an equimolar mixture of Fmoc-/Boc-/Z-α-amino acid and 9-fluorenylmethyl chloroformate for the acylation of diazomethane synth

Homologation of α-amino acids to β-amino acids using Boc2O

The use of Boc2O as a coupling agent in the homologation of N-urethane protected-α-amino acid to its β-homomers by the Arndt-Eistert method is described. The homologation gives good yields without racemization. The use of Boc2O as a

Direct synthesis of N-protected β-amino dimethylhydroxamates: Application to the solid-phase synthesis of a peptide incorporating a new amide bond surrogate ψ[CH2CH2NH]

A rapid and efficient one-step synthesis of N-protected β-amino dimethylhydroxamates starting from diazo ketones is reported. A Fmoc- protected β-amino aldehyde obtained by reduction of its corresponding dimethylhydroxamate was incorporated during solid p

The development of hydrazide γ-Turn mimetics

Monte Carlo calculations show a classical γ-turn in a family of metabolites known as the malformins. This led to the synthesis of epimeric seven-membered ring γ-turn mimetics starting from leucine. NMR temperature coefficient studies were also performed.

Synthesis of Chiral N-Protected α-Amino-β-Diketones from α-Diazoketones Derived from Natural Amino Acids

α-Diazoketols, prepared by condensation of aldehydes or ketones with lithiated optically active α-diazoketones derived from natural amino acids, rearrange to homochiral α-amino-β-diketones on treatment with rhodium(II) acetate.

Synthesis of angiotensin II analogues by incorporating beta-homotyrosine or beta-homoisoleucine residues.

[1-Sarcosine,4-beta-homotyrosine]-(I), [5-beta-homoisoleucine]-(II), and [1-sarcosine,5-beta-homoisoleucine]angiotensin II (III) were synthesized by Merrifield''s solid-phase procedure to study the effect of pressor activity and duration of action. The an